AXIM BIOTECHNOLOGIES, INC. Research And Development Expense

Quick Answer

AXIM BIOTECHNOLOGIES, INC. reported Research And Development Expense of $125.5 thousand for the year ending 2023.

  • AXIM BIOTECHNOLOGIES, INC. showed a decrease of -18.3% in Research And Development Expense from 2022 to 2023.
  • This data is from AXIM BIOTECHNOLOGIES, INC.'s annual report (Form 10-K), filed with the SEC on April 16, 2024.
  • XBRL data for this metric is available from 2016 to 2023 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2016 to 2023), AXIM BIOTECHNOLOGIES, INC.'s Research And Development Expense has declined by 46.7%.
  • Historical annual values: Fiscal year 2023: $125.5 thousand | Fiscal year 2022: $153.7 thousand | Fiscal year 2021: $284.9 thousand | Fiscal year 2018: $2.06 million | Fiscal year 2017: $1.35 million | Fiscal year 2016: $235.6 thousand.
  • Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: